Renal Denervation Devices Market to take a Leap at a CAGR of 41.2% During the Period Between 2012 and 2021

Growing prevalence of hypertension among urban population has significantly contributed to the growth of the global renal denervation devices (RDN) market. Renal sympathetic nerves are directly affected in hypertension. The report cites the increasing cases of treatment resistant hypertension and uncontrolled hypertension as the key factors driving the global renal denervation devices market. Short duration and permanent effect of renal denervation procedure will increase adoption of RDN devices. Further, rapid development of RDN devices and growing geriatric population worldwide will augment the growth of the global renal denervation devices market.

Request Sample for more Comprehensive Analysis @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=400

However, the report mentions that the shortage of clinical evidence is restraining the expansion of the global renal denervation devices market. Lower awareness of RDN devices as compared to drug-based therapy along with unstable reimbursement regulations will hinder the growth of the overall market during the forecast horizon. The report points out that the renal denervation devices market has a huge opportunity to grow in the emerging economies.

On the basis of technology, the global renal denervation devices market has been segmented into ultrasound- based renal denervation systems, renal sympathetic denervation procedure, radiofrequency-based renal denervation systems, and micro-infusion catheter-based renal denervation systems. In 2012, radiofrequency-based RDN devices accounted for the largest share of the market. Due to benefits such as time-efficiency and safety, radiofrequency-based RDN devices will continue to dominate the global renal denervation devices market.

Enquire for Discount @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=400

On the basis of product, the report focuses on ReCor Medical's Paradise, Boston Scientific's (Vessix Vascular) V2, Medtronic's Symplicity, St. Jude's EnlighHTN, and Covidien's OneShot. In 2012, Medtronic’s Symplicity accounted for around 85.5% market share. However, during the forecast period, this product is expected to face stiff competition from other emerging products in the market.

The report studies the global renal denervation devices market across four key regions: Europe, North America, Asia Pacific, and Rest of the World. Europe leads the global renal denervation market owing to a large number of research and development activities and device approvals. The region held 80% of the market in 2012 and is estimated to dominate the overall market during the forecast horizon. Asia Pacific is expected to follow Europe as the second largest market for renal denervation devices.

The report profiles some of the key players in the global renal denervation devices market such as Medtronic Inc., Kona Medical, Boston Scientific Corporation, St. Jude Medical, Covidien PLC, CardioSonic, and Mercator Medsystems.

Request TOC of the Report for Complete Review @ https://www.transparencymarketresearch.com/report-toc/400

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.